이 웹사이트는 국립암센터국제암대학원대학교 공식 웹사이트 입니다.

전체메뉴 바로가기 본문바로가기

교육

교수진 소개

Yul HWANGBO, M.D

Name
Yul HWANGBO, M.D
Faculty Appointment
(title, department)

Assistant Professor, Department of Cancer Control and Population Health
Doctor, Thyroid Cancer Center of National Cancer Center
Doctor, Endocrinology Division of National Cancer Center
Senior Researcher, Convergence Technology Research Department of National Cancer Center
Team Leader, AI Team of National Cancer Center
Team Leader, Information Operations Team of National Cancer Center
Area of Expertise
Gastroenterology, Colorectal Cancer, Endoscopy, Translational Research
E-mail
yulhwangbo@ncc.re.kr
Work Experience
National Cancer Center Thyroid Cancer Center, Doctor (2019~Present)
National Cancer Center Endocrinology Division, Doctor (2019~Present)
National Cancer Center Convergence Technology Research Department, Senior Researcher (2019~Present)
National Cancer Center AI Team, Team Leader (2019~Present)
National Cancer Center Information Operations Team, Team Leader (2019~Present)
Seoul National University Hospital, Intern (2006~2007)
Seoul National University Hospital, Doctor (2007~2011)
Chungcheongnama-do Public Health Doctor (2011~2014)
Seoul National University Hospital, Clinical Lecturer (2014~2015)
Educational Background
M.S., Graduate School of Seoul National University (2000~2006)
M.D., Seoul National University College of Medicine (2010~2015)
Research Interests
Medical treatment of thyroid cancer and thyroid disease, diabetes and endocrine diseases, medical treatment of advanced thyroid cancer
International Collaboration
Achievements
주요논문 (전체: 26 SCI: 14 SCI-E: 3 기타: 9 SSCI: 0 SCI+SCI-E+SSCI: 0 )

2020 SCI Aspirin use is not associated with lower thyroid cancer risk: A nationwide nested case-control study: Thyroid. Online:Published (7.786)

2019 SCI Tumor doubling time predicts response to sorafenib in radioactive iodine-refractory differentiated thyroid cancer: Endocrine journal. 66(7):597~604 (1.94)

2019 SCI Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro): Thyroid. Online:Published (7.786)

2019 SCI Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study: Critical Care Medicine. 47(5):e386~e393 (6.971)

2018 SCI Genome-wide Association Study Reveals Distinct Genetic Susceptibility of Thyroid Nodules from Thyroid Cancer: The Journal of Clinical Endocrinology and Metabolism. 103(12):4384~4394 (5.789)

2018 기타 A Case Report of Severe Hypocalcemia and Hypothyroidism after Tyrosine Kinase Inhibitor Treatment: INTERNATIONAL JOURNAL OF THYROIDOLOGY. 11(2):88~91 (0)

2018 SCI Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females: SCIENTIFIC REPORTS. 8(1):15004~15004 (4.122)

2018 SCI Relation of Subclinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk: The American journal of cardiology. 122(4):571~577 (3.171)

2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)

2018 기타 Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer: Endocrinology and metabolism. 33(2):175~184 (0)

2018 기타 Recent Trends in Serum Vitamin D Levels among Korean Population: Korea National Health and Nutrition Examination Survey 2008∼2014: Korean Journal of Clinical Geriatrics. 19(1):55~62 (0)

2018 SCI-E Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer: Medicine. 97(18):e0590~e0590 (2.028)

2018 SCI Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea: Scientific reports. 8(1):4077~4077 (4.122)

2017 SCI-E Development and Evaluation of a Korean Version of a Thyroid Specific Quality-of-Life Questionnaire Scale in Thyroid Cancer Patient: Cancer Research And Treatment. 50(2):405~415 (3.772)

2017 기타 Secular Trends for Diagnostic Motives and Environmental Risk Factors in Thyroid Cancer Using Questionnaire Survey: Int J Thyroidology. Online:Published (0)

2017 SCI Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer: Nature Communications. 8:15966~15966 (12.124)

2017 기타 Acute Hyperglycemia Associated with Anti-Cancer Medication: Endocrinology and Metabolism. 32:23~29 ()

2016 SCI Long-term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study: The Journal of Clinical Endocrinology & Metabolism. 102(2):625~633 (5.531)

2015 SCI High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women: Osteoporosis International. 27(2):457~462 (4.169)

2015 SCI A Possible Association Between Thyroid Cancer and Breast Cancer: Thyroid. 25(12):1330~1338 (4.493)

2015 SCI Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial: Diabetes Res Clin Pract.. 109(1):141~148 (2.538)

2013 SCI Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.: Acta Diabetol.. 50(4):505~510 (3.679)

2012 기타 Prevalence and clinical characteristics of recently diagnosed type 2 diabetes patients with positive anti-glutamic Acid decarboxylase antibody: Diabetes & Metabolism Journal. 36(2):136~143 ()

2012 기타 Characterization of Incidentally Detected Adrenal Pheochromocytoma: Endocrinology and Metabolism. 27(2):132~137 ()

2011 기타 Association of the Parathyroid Adenoma Volume and the Biochemical Parameters in Primary Hyperparathyroidism: Endocrinology and Metabolism. 26(1):62~66 ()

2011 기타 Malignancy rate in sonographically suspicious thyroid nodules of less than a centimeter in size does not decrease with decreasing size: Journal of Korean Medical Science. 26(2):237~42 (0.993)